| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/12/2002 | WO2001035811A3 Methods of diagnosing and determining prognosis of breast cancer |
| 09/12/2002 | WO2001035102A3 Diagnosis and treatment of malignant neoplasms |
| 09/12/2002 | WO2001030848A3 Nucleic acids of the human abc1 gene and applications thereof |
| 09/12/2002 | WO2001028539A3 Agent for treating cephalic pain |
| 09/12/2002 | WO2001019852A3 Methods of peptide preparation |
| 09/12/2002 | WO2001018175A9 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 09/12/2002 | WO2001017557A9 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 09/12/2002 | WO2001016183A9 Monoclonal antibodies and vaccines against epitopes on the ebola virus glycoprotein |
| 09/12/2002 | WO2001016168A9 Induction of programmed cell death by n5 gene |
| 09/12/2002 | WO2001012651A9 Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neural cell differentiation |
| 09/12/2002 | WO2001010901A9 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 09/12/2002 | WO2001006252A3 Prediction of hepatic failure following hepatitis c |
| 09/12/2002 | WO2001004266A9 A lung cancer associated retrovirus, gene delivery vector and methods of use thereof |
| 09/12/2002 | WO2001002609A3 Method of identifying toxic agents using differential gene expression |
| 09/12/2002 | WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/12/2002 | WO2000072803A3 Streptococcus pneumoniae vaccine strain and uses thereof |
| 09/12/2002 | WO2000069901A3 Proteins with insulin-like activity useful in the treatment of diabetes |
| 09/12/2002 | WO2000066727A9 Tumour-associated antigen |
| 09/12/2002 | WO2000063435A3 Method of identifying toxic agents using differential gene expression |
| 09/12/2002 | US20020129407 Nucleotide sequences coding cell cycle polypeptide for use in detection of modulators fertility in plants |
| 09/12/2002 | US20020129404 CTR1 homologue from melon |
| 09/12/2002 | US20020129397 Transgenic mice containing brain-specific membrane-anchored protein gene disruptions |
| 09/12/2002 | US20020129395 Compositions to identify swine genetically resistant to F18 E. coli associated diseases |
| 09/12/2002 | US20020129393 Expression vector for use in generating genetically engineering animal for use as tool in generating preferential proteins |
| 09/12/2002 | US20020129391 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease |
| 09/12/2002 | US20020129388 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of atherosclerosis |
| 09/12/2002 | US20020129387 Mammals' milk containing recombinant protein for use in human therapeutics |
| 09/12/2002 | US20020129386 High estrogen-sensitive medaka fish |
| 09/12/2002 | US20020128683 Method and apparatus for preparing fibrinogen adhesive from whole blood |
| 09/12/2002 | US20020128463 Polypeptide for use in the treatment and diagnosis of cancer and defects associated with fungal and parasitic infections |
| 09/12/2002 | US20020128462 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of kidney, digestive, fertility, blood pressure and body weight defects |
| 09/12/2002 | US20020128461 Orphan receptor |
| 09/12/2002 | US20020128460 Method for generating hypermutable plants |
| 09/12/2002 | US20020128459 Physiologically active protein originating in mammals |
| 09/12/2002 | US20020128455 Growth factors, nucleic acid encoding them and methods for identification |
| 09/12/2002 | US20020128454 CACNGLIKE3 polypeptides |
| 09/12/2002 | US20020128446 Polypeptide for use in the treatment of cell proliferation and differtiation disorders |
| 09/12/2002 | US20020128445 Nucleic acid encoding a novel human EP prostaglandin receptor |
| 09/12/2002 | US20020128444 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response |
| 09/12/2002 | US20020128443 Polynucleotides encoding thrombin receptor homologs |
| 09/12/2002 | US20020128442 Human proteins STAM2a and STAM2b, and cDNAs encoding these molecules |
| 09/12/2002 | US20020128441 Endoderm, cardiac and neural inducing factors - murine frazzled (FRZB-1) protein |
| 09/12/2002 | US20020128440 Endoderm, cardiac and neural inducing factors - oligonucleotides for expressing human frazzled (frzb-1) protein |
| 09/12/2002 | US20020128439 Protein for use in tumor suppressive gene therapy |
| 09/12/2002 | US20020128438 Expression vector coding preferential protein for use in treatment of cancer; for use in gene therapy |
| 09/12/2002 | US20020128437 Polypeptide for use in the detection of bactericides and prevention, detect and treatment of infections |
| 09/12/2002 | US20020128436 Therapeutic composition for use in the treatment of autoimune and rheumatic diseases |
| 09/12/2002 | US20020128435 Polypeptide for use in treatment of bone and cell proliferation disorders |
| 09/12/2002 | US20020128433 Isolated protein for use as tool in the detection of tastants, olfactants and attractants |
| 09/12/2002 | US20020128250 Modulating the expression of a gene |
| 09/12/2002 | US20020128220 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 09/12/2002 | US20020128219 Novel molecules of the card related protein family and uses thereof |
| 09/12/2002 | US20020128200 Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals |
| 09/12/2002 | US20020128198 Novel molecules of the card-related protein family and uses thereof |
| 09/12/2002 | US20020128197 Recombinant DNA formed by ligating; gene expression; suppressing proliferation; medicine/drugs |
| 09/12/2002 | US20020128196 Localization and characterization of the Wilms' tumor gene |
| 09/12/2002 | US20020128193 Retro-inverso prosaposin-derived peptides and use thereof |
| 09/12/2002 | US20020128192 Insecticides against coleopteran insects including red flour beetle larvae and Japanese beetle larvae (Popillia japonica); transgenic plants having genes encoding crystal protein or peptide; immunodetection kits |
| 09/12/2002 | US20020128191 Topical administration of ophthalmic preparations of bactericidal/permeability-increasing (BPI) protein to reduce hyperemia, chemosis, mucous discharge, neovascularization or ulcer formation |
| 09/12/2002 | US20020128190 Expression of properly folded and soluble extracellular domain of a gonadotropin receptor |
| 09/12/2002 | US20020128189 Ubiquitination of the transcription factor E2A |
| 09/12/2002 | US20020128186 Antimicrobial polypeptide, nucleic acid, and methods of use |
| 09/12/2002 | US20020128183 Gene regulation therapy involving ferritin |
| 09/12/2002 | US20020128182 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 09/12/2002 | US20020128180 Purification method |
| 09/12/2002 | US20020128176 Treatment of erectile dysfunctions with C-Type natriuretic polypeptide (CNP) as a monotherapy or in combination with phosphodiesterase inhibitors |
| 09/12/2002 | US20020128175 Synthetic peptides that enhance atherogenic lipoprotein uptake and lower plasma cholesterol |
| 09/12/2002 | US20020128174 Vp22 proteins and uses thereof |
| 09/12/2002 | US20020127721 Polypeptide for use in the treatment of cancer or genetic disorder |
| 09/12/2002 | US20020127713 Specific tolerance in transplantation |
| 09/12/2002 | US20020127712 Expression vectors coding polypeptide for use in the treatment and preventon of nervous system and inflammatory disorders |
| 09/12/2002 | US20020127702 Methods and compositions for regulating cell cycle progression |
| 09/12/2002 | US20020127700 Methods for improved diagnosis and treatment of mycobacterial infections |
| 09/12/2002 | US20020127698 Serpin drugs for treatment of HIV infection and method of use thereof |
| 09/12/2002 | US20020127690 Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| 09/12/2002 | US20020127689 Novel human galectins |
| 09/12/2002 | US20020127687 Genome DNA of bacterial symbiont of aphids |
| 09/12/2002 | US20020127682 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 09/12/2002 | US20020127676 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 09/12/2002 | US20020127675 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 09/12/2002 | US20020127674 Nucleotide sequences coding polypeptide for use in human therapeutics, and diagnostics, cosmetics and nutrition |
| 09/12/2002 | US20020127673 Nucleotide sequences coding protein for use in the treatment of crohn's disease |
| 09/12/2002 | US20020127672 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 09/12/2002 | US20020127671 52927, a novel human calcium channel and uses thereof |
| 09/12/2002 | US20020127669 Novel compositions for the expression of the human peptide histidine transporter 1 and methods of use thereof |
| 09/12/2002 | US20020127668 Polypeptide for use in the diagnosis and treatment of cancer, nervous system and vessicular transport disorders |
| 09/12/2002 | US20020127663 Nucleotide sequences coding enzymatic polypeptide for use in human generation of amino acids for use in human therapeutics and animal nutrients |
| 09/12/2002 | US20020127661 Polynucleotides coding enzymatic polypeptide for use in generation of amino acid for use in human therapeutics and animal nutrients |
| 09/12/2002 | US20020127657 Proteins for use in the diagnossi and treatment cancer and autoimmune diseases |
| 09/12/2002 | US20020127654 Genetically engineered cell for use as tool in genetic engineering |
| 09/12/2002 | US20020127653 Hematopoietic signaling factor |
| 09/12/2002 | US20020127652 Polypeptide for use in the treatment of mammalian sexual disorders |
| 09/12/2002 | US20020127651 Nucleotide seqences coding transport proteins for use in the diagnosis, treatment and prevention of infection, schock and inflammatory defects |
| 09/12/2002 | US20020127650 32468, a human sugar transporter family member and uses therefor |
| 09/12/2002 | US20020127649 Human potassium channel polynucleotides and polypeptides and uses thereof |
| 09/12/2002 | US20020127648 Novel human C5a-like receptor |
| 09/12/2002 | US20020127647 ATP-binding cassette transporter-like molecules and uses thereof |
| 09/12/2002 | US20020127646 CD38 modulated chemotaxis |
| 09/12/2002 | US20020127644 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/12/2002 | US20020127643 Nucleotide sequences coding membrane proteins for use in human therapeutics and diagnostics |